Paclitaxel and carboplatin in the treatment of small-cell lung cancer patients resistant to cyclophosphamide, doxorubicin, and etoposide: a non-cross-resistant schedule. - Groen,H.J.; Fokkema,E.; Biesma,B. (J Clin Oncol, 1999)